Pradaxa Reversal Agent Approved
November 3, 2015
In 2010, the FDA approved the prescription blood-thinning drug Pradaxa (dabigatran) to prevent stroke and systemic blood clots in patients with atrial fibrillation, as well as for the treatment and prevention of deep venous thrombosis and pulmonary embolism. On October 16, 2015, the FDA granted acc[...]
Continue Reading
Pharmaceutical Company Recalls Empty Gabapentin Capsules
December 5, 2014
On November 21, 2014, the pharmaceutical company Aurobindo Pharma USA announced its voluntary recall of a particular lot (GESB14011-A, expiration date 12/2015) of its Gabapentin Capsules, USP 300 mg 100-count bottles because the lot has been found to contain some empty capsules. The capsules have[...]
Continue Reading